Segment Information (Tables)

12 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The following table summarizes segment information for the years ended December 31, 2019, 2018 and 2017 (in thousands).

	For the Years Ended December 31,
	2019		2018		2017
Net revenues:
Clinical Services	$	361,161	$	241,873	$	213,097
Pharma Services	47,669		34,868		27,154
Total Revenue	408,830		276,741		240,251
Cost of revenue:
Clinical Services	185,612		128,297		121,785
Pharma Services	26,382		21,179		16,510
Total Cost of Revenue	211,994		149,476		138,295
Gross Profit:
Clinical Services	175,549		113,576		91,313
Pharma Services	21,287		13,689		10,643
Total Gross Profit	196,836		127,265		101,956
Operating expenses:
General and administrative	127,993		84,822		70,359
Research and development	8,487		3,001		3,636
Sales and marketing	47,350		29,402		24,001
Loss on sale of Path Logic	—		—		1,058
Total operating expenses	183,830		117,225		99,054
Income from Operations	13,006		10,040		2,902
Interest expense, net	3,713		6,230		5,540
Other expense (income), net	4,630		(14)		12
Loss on extinguishment of debt	1,018		—		—
Income (loss) before taxes	3,645		3,824		(2,650)
Income tax (benefit) expense	(4,361)		1,184		(2,254)
Net income (loss)	$	8,006	$	2,640	$	(396)